Get a Ticket
Home |
AIxBIO Schedule |
Human Health Schedule |
Full Schedule |
Partnering App
Special Pharma Events Wed May 6 | 12:00 pm: Biopharma VIP Lunch | 5.30 pm: AI Reception.
Special Pharma Events Wed May 6
12:00 pm: Biopharma VIP Lunch
5.30 pm: AI Reception.
AI-native drug discovery. $1B backed by ARCH and Foresite.
·
Chairman & CEO
AI cancer therapeutics. Spatial biology and virtual cell models.
Co-Founder & CEO
GPT-Rosalind life sciences model. AI built for drug discovery and biology.
Research Lead
Claude for Life Sciences. Frontier AI for drug discovery and biology research.
Head of Biology & Life Sciences
Silicon photonics for protein sequencing. Stanford spinout, DARPA-backed.
CEO / Professor
AI-powered RNA drug discovery. Targeting the undruggable.
Founder & CEO
AlphaFold team alumni. De novo antibody design.
Virtual cell-signaling models. Designing regenerative therapies.
Co-founder & CEO
Clinical-stage TechBio. World's largest biological dataset.
CSO
100M single-cell dataset. Powering virtual cell models.
CEO & Co-founder
Scientific Co-Founde
Computational drug design at pharma scale. Diabetes, obesity, and rare disease therapies.
VP, CDD
SVP, Global Head
AI protein design platform. Therapeutics to agriculture.
Co-founder
Open-source biomolecular AI. Structure prediction and drug design.
CEO
De novo miniprotein design. Immune and allergy targets.
Co-founder & CSO
AI-designed AAV capsids for gene therapy. Partnered with Novartis.
Biomolecular structure prediction. Open-source Chai-1 model.
AI drug discovery. Small molecules and biologics.
AI co-scientist for life science R&D teams.
Generative protein design. Partnered with AstraZeneca and Takeda.
Hyperscaled protein library design and functional screening.
ML-driven antibody design. Partnered with Lilly and J&J.
CEO & Co-Founder
Multiplexed in vivo protein testing. Barcoded biologics.
AI lab for scientific world models. Biology and drug discovery.
Creators of AlphaFold. AI for scientific discovery.
Senior Program Manager Lead
Silicon-chip DNA synthesis. Powering drug discovery and synthetic biology.
BioNeMo platform. AI infrastructure powering drug discovery at scale.
Director, Digital Biology
Physics + ML for small-molecule drug discovery. Rooted in OpenMM.
iPSC-derived human tissue platform. Scalable data for a biological simulator.
CEO and Co-Founder
Cellular rejuvenation and health. Computational biology at unprecedented scale.
VP, Physics, Molecular & Hybrid Modeling
AI-first protein design. Creators of OpenCRISPR, fully AI-designed gene editors.
Enzymatic DNA synthesis. The complex sequences others can't make.
Computational protein design. Designer enzymes at commercial scale.
Egg-based bioreactors for biologics manufacturing.
Co-Founder & CTO
Fruit-fly biomanufacturing for hard-to-express proteins.
AI bioprocess data platform for biomanufacturing.
Information
